Added to YB: 2023-12-22
Pitch date: 2023-12-22
ESPR [bullish]
Esperion Therapeutics, Inc.
+48.52%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.
Market Cap
$807.5M
Pitch Price
$2.37
Price Target
N/A
Dividend
N/A
EV/EBITDA
-53.12
P/E
-6.40
EV/Sales
4.33
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Esperion Therapeutics Inc ESPR
A summary for this pitch has not been created yet.
Read full article (0 min)